S&D Co (260970) Q1 2025 earnings summary

Executive summary

• Achieved Q1 2025 revenue of 35.7 billion KRW, up 50% year-over-year, with net income of 4.39 billion KRW, up 55% year-over-year.

• Main business is development, manufacturing, and sales of functional food ingredients and health supplements.

• No subsidiaries or changes in affiliated companies as of the reporting date.

• Maintains A/A+ credit ratings from major agencies.

Financial highlights

• Q1 2025 revenue: 35.7 billion KRW (Q1 2024: 23.8 billion KRW).

• Operating income: 5.38 billion KRW (Q1 2024: 3.51 billion KRW).

• Net income: 4.39 billion KRW (Q1 2024: 2.83 billion KRW).

• Gross margin: 21.4% (Q1 2024: 24.0%).

• Basic EPS: 1,518 KRW (Q1 2024: 698 KRW).

Outlook and guidance

• No specific forward guidance provided; company is preparing for expansion into finished product markets and new business areas.

• Recent business purpose amendments to enable diversification, but no immediate new business launches.